Vermont’s homegrown companies might find themselves pitted against larger out-of-state businesses due to the sates regulatory system. Three medical cannabis businesses – including multistate operators Curaleaf and iAnthus Capital Holdings – are poised to take advantage of a five-month head start in sales in the spring of 2022. All the cannabis MSO are backed by large cultivation and processing facilities. Then, small producers and retailers will follow. The new market comes after Vermont on Oct. 7 became the 11th state to legalize adult-use sales. Marijuana insiders believe smaller, homegrown companies could benefit given that the new law allows businesses to operate only one marijuana retail store.

Marijuana Business Daily, 10/14/2020 06:30:34

Open article: